ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

photonamic gmbh & co. kg - 5-aminolevulinsyrehydrochlorid - gliom - antineoplastiske midler - gliolan er indiceret hos voksne patienter til visualisering af malignt væv under operationen for malignt gliom (verdenssundhedsorganisation iii og iv).

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

photonamic gmbh & co. kg - 5-aminolevulinsyre - medicinsk plaster - 8 mg

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

roche registration gmbh - vemurafenib - melanom - antineoplastiske midler - vemurafenib er indiceret som monoterapi til behandling af voksne patienter med braf-v600-mutations-positiv uopløselig eller metastatisk melanom.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - rekombinant vesikulær stomatitis virus (stamme, indiana) med en sletning af konvolutten glycoprotein, som er erstattet med zaire ebolavirus (stamme kikwit 1995) overflade glycoprotein - hæmoragisk feber, ebola - vacciner - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. brug af ervebo bør være i overensstemmelse med de officielle anbefalinger.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

astrazeneca ab - gefitinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - iressa er indiceret til behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke-small-cell lung cancer med aktiverende mutationer af epidermal-growth-factor-receptor tyrosin kinase.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - gefitinib - filmovertrukne tabletter - 250 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - gefitinib - filmovertrukne tabletter - 250 mg

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - sunitinib - kapsler, hårde - 12,5 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - sunitinib - kapsler, hårde - 25 mg